Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · IEX Real-Time Price · USD
38.80
-2.48 (-6.01%)
At close: Jul 2, 2024, 4:00 PM
38.51
-0.29 (-0.75%)
After-hours: Jul 2, 2024, 7:56 PM EDT
Avidity Biosciences Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Avidity Biosciences stock have an average target of 45.86, with a low estimate of 30 and a high estimate of 60. The average target predicts an increase of 18.20% from the current stock price of 38.80.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RNA stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $40 → $45 | Strong Buy | Maintains | $40 → $45 | +15.98% | Jun 13, 2024 |
| Needham | Needham | Strong Buy Maintains $35 → $46 | Strong Buy | Maintains | $35 → $46 | +18.56% | Jun 12, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $33 → $45 | Strong Buy | Maintains | $33 → $45 | +15.98% | Jun 12, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $40 → $45 | Buy | Maintains | $40 → $45 | +15.98% | Jun 12, 2024 |
| Needham | Needham | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | -9.79% | Jun 10, 2024 |
Financial Forecast
Revenue This Year
13.06M
from 9.56M
Increased by 36.57%
Revenue Next Year
10.73M
from 13.06M
Decreased by -17.84%
EPS This Year
-3.23
from -2.91
EPS Next Year
-3.44
from -3.23
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 26.1M | 29.8M | 257.9M | 827.8M | 1.5B |
| Avg | 13.1M | 10.7M | 86.8M | 374.7M | 864.2M |
| Low | n/a | n/a | 9.8M | 78.4M | 218.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 172.6% | 128.1% | 2,303.7% | 854.2% | 309.1% |
| Avg | 36.6% | -17.8% | 708.7% | 332.0% | 130.6% |
| Low | - | - | -8.6% | -9.6% | -41.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.60 | -2.38 | -1.09 | 2.23 | 8.33 |
| Avg | -3.23 | -3.44 | -3.23 | -0.90 | 3.73 |
| Low | -3.88 | -4.30 | -4.33 | -4.59 | -2.39 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.